COVID-19 Impact on Global Type 2 Diabetes Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 96 pages | ID: C90B2F0512C5EN
QYResearch

Abstracts

This report focuses on the global Type 2 Diabetes Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Type 2 Diabetes Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AstraZeneca
• Novartis
• Novo Nordisk
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Eli Lilly
• Merck
• Sanofi

Market segment by Type, the product can be split into

• DPP-4 Inhibitors
• Biguanides
• Insulins
• SGLT-2 Inhibitors
• ?-Glucosidase Inhibitors
• Other

Market segment by Application, split into

• Children
• Middle-Aged Person
• Aged

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Type 2 Diabetes Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Type 2 Diabetes Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Type 2 Diabetes Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Type 2 Diabetes Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Type 2 Diabetes Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 DPP-4 Inhibitors
  1.4.3 Biguanides
  1.4.4 Insulins
  1.4.5 SGLT-2 Inhibitors
  1.4.6 ?-Glucosidase Inhibitors
  1.4.7 Other
1.5 Market by Application
  1.5.1 Global Type 2 Diabetes Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Children
  1.5.3 Middle-Aged Person
  1.5.4 Aged
1.6 Coronavirus Disease 2019 (Covid-19): Type 2 Diabetes Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Type 2 Diabetes Therapeutics Industry
    1.6.1.1 Type 2 Diabetes Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Type 2 Diabetes Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Type 2 Diabetes Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Type 2 Diabetes Therapeutics Market Perspective (2015-2026)
2.2 Type 2 Diabetes Therapeutics Growth Trends by Regions
  2.2.1 Type 2 Diabetes Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Type 2 Diabetes Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Type 2 Diabetes Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Type 2 Diabetes Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Type 2 Diabetes Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Type 2 Diabetes Therapeutics Players by Market Size
  3.1.1 Global Top Type 2 Diabetes Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Type 2 Diabetes Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Type 2 Diabetes Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Type 2 Diabetes Therapeutics Market Concentration Ratio
  3.2.1 Global Type 2 Diabetes Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Therapeutics Revenue in 2019
3.3 Type 2 Diabetes Therapeutics Key Players Head office and Area Served
3.4 Key Players Type 2 Diabetes Therapeutics Product Solution and Service
3.5 Date of Enter into Type 2 Diabetes Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Type 2 Diabetes Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Type 2 Diabetes Therapeutics Forecasted Market Size by Type (2021-2026)

5 TYPE 2 DIABETES THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Type 2 Diabetes Therapeutics Market Size by Application (2015-2020)
5.2 Global Type 2 Diabetes Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Type 2 Diabetes Therapeutics Market Size (2015-2020)
6.2 Type 2 Diabetes Therapeutics Key Players in North America (2019-2020)
6.3 North America Type 2 Diabetes Therapeutics Market Size by Type (2015-2020)
6.4 North America Type 2 Diabetes Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Type 2 Diabetes Therapeutics Market Size (2015-2020)
7.2 Type 2 Diabetes Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Type 2 Diabetes Therapeutics Market Size by Type (2015-2020)
7.4 Europe Type 2 Diabetes Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Type 2 Diabetes Therapeutics Market Size (2015-2020)
8.2 Type 2 Diabetes Therapeutics Key Players in China (2019-2020)
8.3 China Type 2 Diabetes Therapeutics Market Size by Type (2015-2020)
8.4 China Type 2 Diabetes Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Type 2 Diabetes Therapeutics Market Size (2015-2020)
9.2 Type 2 Diabetes Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Type 2 Diabetes Therapeutics Market Size by Type (2015-2020)
9.4 Japan Type 2 Diabetes Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Type 2 Diabetes Therapeutics Market Size (2015-2020)
10.2 Type 2 Diabetes Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Type 2 Diabetes Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Type 2 Diabetes Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Type 2 Diabetes Therapeutics Market Size (2015-2020)
11.2 Type 2 Diabetes Therapeutics Key Players in India (2019-2020)
11.3 India Type 2 Diabetes Therapeutics Market Size by Type (2015-2020)
11.4 India Type 2 Diabetes Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Type 2 Diabetes Therapeutics Market Size (2015-2020)
12.2 Type 2 Diabetes Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Type 2 Diabetes Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Type 2 Diabetes Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AstraZeneca
  13.1.1 AstraZeneca Company Details
  13.1.2 AstraZeneca Business Overview and Its Total Revenue
  13.1.3 AstraZeneca Type 2 Diabetes Therapeutics Introduction
  13.1.4 AstraZeneca Revenue in Type 2 Diabetes Therapeutics Business (2015-2020))
  13.1.5 AstraZeneca Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Type 2 Diabetes Therapeutics Introduction
  13.2.4 Novartis Revenue in Type 2 Diabetes Therapeutics Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Novo Nordisk
  13.3.1 Novo Nordisk Company Details
  13.3.2 Novo Nordisk Business Overview and Its Total Revenue
  13.3.3 Novo Nordisk Type 2 Diabetes Therapeutics Introduction
  13.3.4 Novo Nordisk Revenue in Type 2 Diabetes Therapeutics Business (2015-2020)
  13.3.5 Novo Nordisk Recent Development
13.4 Boehringer Ingelheim
  13.4.1 Boehringer Ingelheim Company Details
  13.4.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.4.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Introduction
  13.4.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Therapeutics Business (2015-2020)
  13.4.5 Boehringer Ingelheim Recent Development
13.5 Bristol-Myers Squibb
  13.5.1 Bristol-Myers Squibb Company Details
  13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.5.3 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Introduction
  13.5.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Therapeutics Business (2015-2020)
  13.5.5 Bristol-Myers Squibb Recent Development
13.6 Eli Lilly
  13.6.1 Eli Lilly Company Details
  13.6.2 Eli Lilly Business Overview and Its Total Revenue
  13.6.3 Eli Lilly Type 2 Diabetes Therapeutics Introduction
  13.6.4 Eli Lilly Revenue in Type 2 Diabetes Therapeutics Business (2015-2020)
  13.6.5 Eli Lilly Recent Development
13.7 Merck
  13.7.1 Merck Company Details
  13.7.2 Merck Business Overview and Its Total Revenue
  13.7.3 Merck Type 2 Diabetes Therapeutics Introduction
  13.7.4 Merck Revenue in Type 2 Diabetes Therapeutics Business (2015-2020)
  13.7.5 Merck Recent Development
13.8 Sanofi
  13.8.1 Sanofi Company Details
  13.8.2 Sanofi Business Overview and Its Total Revenue
  13.8.3 Sanofi Type 2 Diabetes Therapeutics Introduction
  13.8.4 Sanofi Revenue in Type 2 Diabetes Therapeutics Business (2015-2020)
  13.8.5 Sanofi Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Type 2 Diabetes Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Type 2 Diabetes Therapeutics Revenue
Table 3. Ranking of Global Top Type 2 Diabetes Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Type 2 Diabetes Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of DPP-4 Inhibitors
Table 6. Key Players of Biguanides
Table 7. Key Players of Insulins
Table 8. Key Players of SGLT-2 Inhibitors
Table 9. Key Players of ?-Glucosidase Inhibitors
Table 10. Key Players of Other
Table 11. COVID-19 Impact Global Market: (Four Type 2 Diabetes Therapeutics Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Type 2 Diabetes Therapeutics Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Type 2 Diabetes Therapeutics Players to Combat Covid-19 Impact
Table 16. Global Type 2 Diabetes Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Type 2 Diabetes Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Type 2 Diabetes Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Type 2 Diabetes Therapeutics Market Share by Regions (2015-2020)
Table 20. Global Type 2 Diabetes Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Type 2 Diabetes Therapeutics Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Type 2 Diabetes Therapeutics Market Growth Strategy
Table 26. Main Points Interviewed from Key Type 2 Diabetes Therapeutics Players
Table 27. Global Type 2 Diabetes Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 28. Global Type 2 Diabetes Therapeutics Market Share by Players (2015-2020)
Table 29. Global Top Type 2 Diabetes Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 2 Diabetes Therapeutics as of 2019)
Table 30. Global Type 2 Diabetes Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Type 2 Diabetes Therapeutics Product Solution and Service
Table 33. Date of Enter into Type 2 Diabetes Therapeutics Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Type 2 Diabetes Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. Global Type 2 Diabetes Therapeutics Market Size Share by Type (2015-2020)
Table 37. Global Type 2 Diabetes Therapeutics Revenue Market Share by Type (2021-2026)
Table 38. Global Type 2 Diabetes Therapeutics Market Size Share by Application (2015-2020)
Table 39. Global Type 2 Diabetes Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. Global Type 2 Diabetes Therapeutics Market Size Share by Application (2021-2026)
Table 41. North America Key Players Type 2 Diabetes Therapeutics Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Type 2 Diabetes Therapeutics Market Share (2019-2020)
Table 43. North America Type 2 Diabetes Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. North America Type 2 Diabetes Therapeutics Market Share by Type (2015-2020)
Table 45. North America Type 2 Diabetes Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. North America Type 2 Diabetes Therapeutics Market Share by Application (2015-2020)
Table 47. Europe Key Players Type 2 Diabetes Therapeutics Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Type 2 Diabetes Therapeutics Market Share (2019-2020)
Table 49. Europe Type 2 Diabetes Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Type 2 Diabetes Therapeutics Market Share by Type (2015-2020)
Table 51. Europe Type 2 Diabetes Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Type 2 Diabetes Therapeutics Market Share by Application (2015-2020)
Table 53. China Key Players Type 2 Diabetes Therapeutics Revenue (2019-2020) (Million US$)
Table 54. China Key Players Type 2 Diabetes Therapeutics Market Share (2019-2020)
Table 55. China Type 2 Diabetes Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. China Type 2 Diabetes Therapeutics Market Share by Type (2015-2020)
Table 57. China Type 2 Diabetes Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. China Type 2 Diabetes Therapeutics Market Share by Application (2015-2020)
Table 59. Japan Key Players Type 2 Diabetes Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Type 2 Diabetes Therapeutics Market Share (2019-2020)
Table 61. Japan Type 2 Diabetes Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Type 2 Diabetes Therapeutics Market Share by Type (2015-2020)
Table 63. Japan Type 2 Diabetes Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Type 2 Diabetes Therapeutics Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Type 2 Diabetes Therapeutics Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Type 2 Diabetes Therapeutics Market Share (2019-2020)
Table 67. Southeast Asia Type 2 Diabetes Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Type 2 Diabetes Therapeutics Market Share by Type (2015-2020)
Table 69. Southeast Asia Type 2 Diabetes Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Type 2 Diabetes Therapeutics Market Share by Application (2015-2020)
Table 71. India Key Players Type 2 Diabetes Therapeutics Revenue (2019-2020) (Million US$)
Table 72. India Key Players Type 2 Diabetes Therapeutics Market Share (2019-2020)
Table 73. India Type 2 Diabetes Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. India Type 2 Diabetes Therapeutics Market Share by Type (2015-2020)
Table 75. India Type 2 Diabetes Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. India Type 2 Diabetes Therapeutics Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Type 2 Diabetes Therapeutics Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Type 2 Diabetes Therapeutics Market Share (2019-2020)
Table 79. Central & South America Type 2 Diabetes Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Type 2 Diabetes Therapeutics Market Share by Type (2015-2020)
Table 81. Central & South America Type 2 Diabetes Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Type 2 Diabetes Therapeutics Market Share by Application (2015-2020)
Table 83. AstraZeneca Company Details
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Product
Table 86. AstraZeneca Revenue in Type 2 Diabetes Therapeutics Business (2015-2020) (Million US$)
Table 87. AstraZeneca Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Product
Table 91. Novartis Revenue in Type 2 Diabetes Therapeutics Business (2015-2020) (Million US$)
Table 92. Novartis Recent Development
Table 93. Novo Nordisk Company Details
Table 94. Novo Nordisk Business Overview
Table 95. Novo Nordisk Product
Table 96. Novo Nordisk Revenue in Type 2 Diabetes Therapeutics Business (2015-2020) (Million US$)
Table 97. Novo Nordisk Recent Development
Table 98. Boehringer Ingelheim Company Details
Table 99. Boehringer Ingelheim Business Overview
Table 100. Boehringer Ingelheim Product
Table 101. Boehringer Ingelheim Revenue in Type 2 Diabetes Therapeutics Business (2015-2020) (Million US$)
Table 102. Boehringer Ingelheim Recent Development
Table 103. Bristol-Myers Squibb Company Details
Table 104. Bristol-Myers Squibb Business Overview
Table 105. Bristol-Myers Squibb Product
Table 106. Bristol-Myers Squibb Revenue in Type 2 Diabetes Therapeutics Business (2015-2020) (Million US$)
Table 107. Bristol-Myers Squibb Recent Development
Table 108. Eli Lilly Company Details
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Product
Table 111. Eli Lilly Revenue in Type 2 Diabetes Therapeutics Business (2015-2020) (Million US$)
Table 112. Eli Lilly Recent Development
Table 113. Merck Company Details
Table 114. Merck Business Overview
Table 115. Merck Product
Table 116. Merck Revenue in Type 2 Diabetes Therapeutics Business (2015-2020) (Million US$)
Table 117. Merck Recent Development
Table 118. Sanofi Business Overview
Table 119. Sanofi Product
Table 120. Sanofi Company Details
Table 121. Sanofi Revenue in Type 2 Diabetes Therapeutics Business (2015-2020) (Million US$)
Table 122. Sanofi Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Type 2 Diabetes Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. DPP-4 Inhibitors Features
Figure 3. Biguanides Features
Figure 4. Insulins Features
Figure 5. SGLT-2 Inhibitors Features
Figure 6. ?-Glucosidase Inhibitors Features
Figure 7. Other Features
Figure 8. Global Type 2 Diabetes Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Children Case Studies
Figure 10. Middle-Aged Person Case Studies
Figure 11. Aged Case Studies
Figure 12. Type 2 Diabetes Therapeutics Report Years Considered
Figure 13. Global Type 2 Diabetes Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Type 2 Diabetes Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Type 2 Diabetes Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Type 2 Diabetes Therapeutics Market Share by Players in 2019
Figure 18. Global Top Type 2 Diabetes Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 2 Diabetes Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Type 2 Diabetes Therapeutics Revenue in 2019
Figure 20. North America Type 2 Diabetes Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Type 2 Diabetes Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Type 2 Diabetes Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Type 2 Diabetes Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Type 2 Diabetes Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Type 2 Diabetes Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Type 2 Diabetes Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2015-2020)
Figure 31. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2015-2020)
Figure 33. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2015-2020)
Figure 35. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Bristol-Myers Squibb Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2015-2020)
Figure 37. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2015-2020)
Figure 39. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Merck Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2015-2020)
Figure 41. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Sanofi Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed